Facebook
Twitter
Telegram
Report an ErrorCytomX Therapeutics Financial Statements 2011-2024 | CTMX
Annual Financial Statements CytomX Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
185 M | 119 M | 283 M | 305 M | 377 M | 697 M | 1.02 B | 411 M | 135 M | - | - | - | - |
Shares |
73.8 M | 65.7 M | 65.3 M | 46.6 M | 45.3 M | 41.7 M | 37.2 M | 36.2 M | 8.6 M | - | - | - | - |
Historical Prices |
2.51 | 1.81 | 4.33 | 6.55 | 8.31 | 15.1 | 21.1 | 11 | 20.9 | - | - | - | - |
Net Income |
-569 K | -99.3 M | -34.8 M | -24 M | -133 M | -84.6 M | -43.1 M | -58.9 M | -35.4 M | -30.3 M | -15.1 M | - | - |
Revenue |
101 M | 53.2 M | 37.3 M | 68.4 M | 26.9 M | 59.5 M | 71.6 M | 15 M | 7.71 M | 5.08 M | 888 K | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | 7.71 M | 5.08 M | 888 K | - | - |
Operating Income |
-6.48 M | -101 M | -34.9 M | -24.1 M | -141 M | -77.9 M | -46.3 M | -59.6 M | -33.2 M | -29.8 M | -15 M | - | - |
Interest Expense |
-30 K | 340 K | 7 K | -29 K | -135 K | -68 K | -27 K | 1.69 M | 1.73 M | 487 K | 254 K | - | - |
EBITDA |
-4.48 M | -99 M | -32.3 M | -21.7 M | -139 M | -76 M | -44.6 M | -57.9 M | -32 M | -29 M | -14.3 M | - | - |
Operating Expenses |
108 M | 154 M | 46 M | 31.2 M | 168 M | 137 M | 118 M | 74.6 M | 40.9 M | 34.8 M | 15.8 M | - | - |
General and Administrative Expenses |
30 M | 42.8 M | 9.46 M | 9.14 M | 36.8 M | 33.5 M | 25.6 M | 19.9 M | 12.6 M | 6.54 M | 4.95 M | - | - |
All numbers in USD currency
Quarterly Income Statement CytomX Therapeutics
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
82 M | 80.7 M | 66.5 M | 66.2 M | - | 65.9 M | 65.5 M | 65.4 M | 65.4 M | 65.2 M | 65.1 M | 61 M | 48.3 M | 46.2 M | 46.1 M | 45.7 M | 45.5 M | 45.4 M | 45.3 M | 45.1 M | 45.1 M | 43.9 M | 39 M | 38.6 M | 38.5 M | 36.9 M | 36.8 M | 36.5 M | 36.5 M | 36.3 M | 36.1 M | 36.1 M | 36 M | 1.04 M | 1 M | 997 K | 997 K | 979 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
13.8 M | 2.99 M | -1.09 M | -3.31 M | - | -29.1 M | -29.5 M | -32 M | - | -22.6 M | -19.2 M | -15.6 M | - | -14.7 M | -15.7 M | 12.2 M | -35.5 M | -23.7 M | -29 M | -14.1 M | -32.2 M | -23.4 M | -13.4 M | -15.5 M | 621 K | -10.2 M | -25.2 M | -8.26 M | -14 M | -14.7 M | -14.2 M | -16 M | -11.5 M | -11.9 M | -5.81 M | -6.21 M | -4.79 M | -3.59 M | -4.93 M | -17 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
41.5 M | 26.4 M | 24.7 M | 23.5 M | - | 11.1 M | 12.9 M | 9.04 M | - | 17.6 M | 16.3 M | 16 M | - | 17.8 M | 16.6 M | 49.6 M | 8.28 M | 10.7 M | 9.01 M | 29.5 M | 11.5 M | 12.5 M | 21.3 M | 14.2 M | 27.1 M | 24.1 M | 8.75 M | 11.7 M | 6.27 M | 3.45 M | 3.09 M | 2.22 M | 1.99 M | 1.94 M | 2.04 M | 1.74 M | 1.86 M | 1.92 M | 666 K | 635 K | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
11.7 M | 3.12 M | -3.35 M | -5.65 M | - | -29.7 M | -30.1 M | -32.1 M | - | -22.6 M | -19.2 M | -15.6 M | - | -14.9 M | -16.1 M | -2.79 M | - | -25.7 M | -31.2 M | -16.6 M | -25.8 M | -23.2 M | -13.3 M | -15.6 M | - | -11 M | -25.4 M | -8.61 M | - | -14.9 M | -14.3 M | -16.2 M | - | -11.3 M | -5.54 M | -4.87 M | - | -3.46 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-11 K | -7 K | -47 K | 15 K | - | 30 K | 296 K | 13 K | - | -13 K | -82 K | 5 K | - | -15 K | 5 K | 12 K | - | 22 K | -88 K | -61 K | - | 29 K | 61 K | -140 K | - | -47 K | -174 K | 206 K | - | 482 K | 465 K | 353 K | - | 718 K | 408 K | 230 K | - | 117 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
11.7 M | - | - | -5.62 M | - | -29.6 M | -30.1 M | -32 M | - | -22.5 M | -19.2 M | -15.6 M | - | -14.8 M | -16.1 M | -2.76 M | - | -25.6 M | -31.2 M | -15.9 M | -25.8 M | -23.1 M | -12.5 M | -15.3 M | - | -9.78 M | -25 M | -8.22 M | - | -14.5 M | -13.8 M | -15.8 M | - | -11 M | -5.24 M | -4.6 M | - | -2.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
29.8 M | 23.3 M | 28.1 M | 29.2 M | - | 40.9 M | 42.9 M | 41.1 M | - | 40.2 M | 35.5 M | 31.6 M | - | 32.7 M | 32.7 M | 52.4 M | - | 36.4 M | 40.2 M | 46 M | - | 35.7 M | 34.6 M | 29.8 M | - | 35.2 M | 34.1 M | 20.3 M | - | 18.4 M | 17.4 M | 18.4 M | - | 13.2 M | 7.58 M | 6.61 M | - | 5.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.75 M | 6.81 M | 7.4 M | 7.98 M | - | 10.5 M | 11.7 M | 10.5 M | - | 11.1 M | 9.39 M | 9.23 M | - | 8.63 M | 8.68 M | 9.57 M | - | 8.46 M | 9.41 M | 9.67 M | - | 8.14 M | 9.04 M | 7.36 M | - | 6.25 M | 6.05 M | 5.69 M | - | 5.03 M | 4.65 M | 5.04 M | - | 4.05 M | 2.55 M | 1.95 M | - | 1.46 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency